| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.14 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |